Showing results (51-60 of 738) with videos related to
Sort By:
Pageof 74
Medical Hypotheses|December 5, 2006
Intensive glycemic control in diabetic pregnancy with intrauterine growth restriction is detrimental to fetusRakesh M Parikh, Shashank R Joshi, Padmavathy S Menon, et al.Medical Hypotheses|December 13, 2006
Index of central obesity - A novel parameterRakesh M Parikh, Shashank R Joshi, Padmavathy S Menon, et al.Diabetes & Metabolic Syndrome|July 14, 2023
Non-sugar sweeteners and health outcomes in adults without diabetes: deciphering the WHO recommendations in the Indian contextAwadhesh Kumar Singh, Akriti Singh, Ritu Singh, et al.Journal of the Indian Medical Association|December 22, 2005
Study of efficacy and safety of losartan (losar) in Asian Indian hypertensivesShashank R Joshi, Shailaja Kale, Abraham Oomman, et al.Drug Design, Development and Therapy|July 3, 2020
Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in TherapyViswanathan Mohan, Ambrish Mithal, Shashank R Joshi, et al.Expert Opinion on Pharmacotherapy|August 11, 2015
Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based reviewShashank R Joshi, Eberhard Standl, Nanwei Tong, et al.Expert Opinion on Pharmacotherapy|June 26, 2014
Acarbose plus metformin fixed-dose combination in the management of type 2 diabetesShashank R Joshi, Ambady Ramachandran, Manoj Chadha, et al.Expert Opinion on Biological Therapy|August 22, 2022
Biosimilars and interchangeable biosimilars: facts every prescriber, payor, and patient should know. Insulins perspectiveShashank R Joshi, Shivani Mittra, Praveen Raj, et al.The Journal of the Association of Physicians of India|June 15, 2018
Effect of Low (7.5 mg/day), Standard (15 mg/ day) and High (30 mg/day) Dose Pioglitazone Therapy on Glycemic Control and Weight Gain in Recently-Diagnosed Type 2 Diabetes PatientsVijay Panikar, Namdev J Kale, Sumedh S Hoskote, et al.The Journal of the Association of Physicians of India|June 24, 2025
Revisiting Diabetes Classification: Insights Challenges and Clinical Relevance of the ANDIS Framework in the Indian ContextAkriti Singh, Shambo S Samajdar, Awadhesh K Singh, et al.Pageof 74